2022 ´ëÇѺñ¸¸ÇÐȸ Á¦55Â÷ Ãá°èÇмú´ëȸ : 2022-03-12±³À°ÀÏÀÚ : 2022-03-12
±³À°Àå¼Ò : ¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ (*¿ÀÇÁ¶óÀÎ: ±×·£µå ¿öÄ¿Èú ¼¿ï)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) 2022 ´ëÇѺñ¸¸ÇÐȸ Á¦55Â÷ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѺñ¸¸ÇÐȸ
´ã´çÀÚ : °¶ó¿µ
¿¬¶ôó : 02-6941-0888
À̸ÞÀÏ :
obesity@kosso.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 21 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-12 Room 1 08:00~08:50 ºñ¸¸È¯ÀÚ¿¡¼ÀÇ ¸®³ª±Û¸³Æ¾ ÇѺ´´ö(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 03-12 Room 2 08:00~08:50 ºñ¸¸È¯ÀÚ¿¡¼ÀÇ ´ç´¢º´¾à¹° ¼±Åà ¼ÕÀå¿ø(°¡Å縯ÀÇ´ë ºÎõ¼º¸ðº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03-12 Room 1 09:00~09:20 Clinical research data of Tirzepatide and Semaglutide Á¤Ã¢Èñ(¿ï»êÀÇ´ë ³»°ú)
±³À°½Ã°£ 03-12 Room 1 09:20~09:40 Combination therapy of anti-diabetic and anti-obesity agents È«ÁØÈ(À»ÁöÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03-12 Room 1 09:40~10:00 Upcoming novel combinations of anti-obesity therapeutics ÀüÀçÇÑ(°æºÏÀÇ´ë ³»°ú)
Åä·Ð 03-12 Room 1 10:00~10:20 ÆгÎÅäÀÇ ¹®Áؼº, À±Áö¿Ï(¿µ³²ÀÇ´ë ³»°ú, ¼¿ïÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03-12 Room 2 09:00~09:20 Hypothalamic inflammation in the control of metabolic function ±è¹Î¼ö(KIST)
±³À°½Ã°£ 03-12 Room 2 09:20~09:40 ºñ¸¸ °ü·Ã È£¸£¸ó Á¤¿ëÅÃ(°í·Á´ë)
±³À°½Ã°£ 03-12 Room 2 09:40~10:00 Dopaminergic control of food intake: Role of dopamine D2 receptor ¹éÀÚÇö(°í·Á´ë)
Åä·Ð 03-12 Room 2 10:00~10:20 ÆгÎÅäÀÇ ±è¿øÁØ(°¸ª¾Æ»êº´¿ø)
±³À°½Ã°£ 03-12 Room 3 09:00~09:20 Live imaging of peripheral taste sensation ÃÖ¸íȯ(¼¿ï´ëÇб³ »ý¸í°úÇкÎ)
±³À°½Ã°£ 03-12 Room 3 09:20~09:40 History and types of alternative sweeteners À¯»óÈ£(¼¼Á¾´ëÇб³ ½ÄÇ°°øÇаú)
±³À°½Ã°£ 03-12 Room 3 09:40~10:00 Application of alternative sweeteners in diet management of chronic disease ÀÌÇý¿Á(±¹¸³Áß¾ÓÀÇ·á¿ø ÀÓ»ó¿µ¾çÆÀ)
Åä·Ð 03-12 Room 3 10:00~10:20 ÆгÎÅäÀÇ ÀÓÇöÁ¤, ÀÌÀºÁ¤(°æÈñ´ë ½ÄÇ°¿µ¾çÇаú, ¼º±Õ°üÀÇ´ë °ºÏ»ï¼ºº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03-12 Room 1 10:30~11:30 Comprehensive Perspective on Obesity in Koreans ¹ÚÇý¼ø(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 03-12 Room 1 11:30~12:30 ½ºÅ¸Æ¾, ¿¡Á¦Æ¼¹Ìºê º¹ÇÕÁ¦ÀÇ ÃֽŠ°æÇâ ÇѺ´´ö(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 03-12 Room 1 12:30~12:45 ºñ¸¸ÀÇ Áø´Ü ±è¾çÇö(°í·ÁÀÇ´ë °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 03-12 Room 1 12:45~13:00 üÁß°¨·® ÈÄ À¯Áö È«ÁØÈ(À»ÁöÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03-12 Room 1 13:00~13:15 Á¤½Å°ú ÁúȯÀÌ µ¿¹ÝµÈ ºñ¸¸È¯ÀÚ ±è½ÂÁØ(°Ç¾çÀÇ´ë Á¤½Å°Ç°ÀÇÇаú)
Åä·Ð 03-12 Room 1 13:15~13:50 ÆгÎÅäÀÇ ±è¼º¼ö, ±èÁ¾È, ±è°æ°ï, ±Ç´ëÀÍ, Á¤Áö¿¬(Ãæ³²ÀÇ´ë °¡Á¤ÀÇÇаú, ¼¼Á¾º´¿ø ³»ºÐºñ³»°ú, °¡ÃµÀÇ´ë °¡Á¤ÀÇÇаú, Çѱ¹ÀϺ¸, Çѱ¹¼ÒºñÀÚ¿¬¸Í »ç¹«ÃÑÀå)
±³À°½Ã°£ 03-12 Room 2 12:30~14:00 Oral Presentation 2 ÀÓ¼ö(¼¿ïÀÇ´ë ºÐ´ç¼¿ï´ëº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03-12 Room 3 12:30~14:00 Oral Presentation 3 ¼ÕÀå¿ø(°¡Å縯ÀÇ´ë ºÎõ¼º¸ðº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03-12 Room 1 14:00~14:20 Introduction of MAFLD ±¸º¸°æ(¼¿ïÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03-12 Room 1 14:20~14:40 Current treatment option ÀÌ¿ëÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03-12 Room 1 14:40~15:00 new target Àü´ë¿ø(ÇѾçÀÇ´ë ¼Òȱ⳻°ú)
Åä·Ð 03-12 Room 1 15:00~15:20 ÆгÎÅäÀÇ À̽Âȯ, ¿À¹üÁ¶(¼¿ï¼º¸ðº´¿ø, ¼¿ïÀÇ´ë º¸¶ó¸Åº´¿ø)
±³À°½Ã°£ 03-12 Room 2 14:00~14:20 ºñ¸¸ ±âÃÊ °ÀÇ1 ±èÀç¹ü(¼¿ï´ë »ý¸í°úÇкÎ)
±³À°½Ã°£ 03-12 Room 2 14:20~14:40 Organ crosstalk to control metabolic homeostasis: from intestine to adipose tissue Ȳ¼º¼ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03-12 Room 2 14:40~15:00 ºñ¸¸ ±âÃÊ °ÀÇ2 ¼Àç¸í(Ä«À̽ºÆ® ÀÇ°úÇдëÇпø)
Åä·Ð 03-12 Room 2 15:00~15:20 ÆгÎÅäÀÇ ÀÌÀ±Èñ, ¹ÚŽÄ(¼¿ï´ë ¾à´ë ºÎ±³¼ö, °¡Ãµ´ë »ý¸í°úÇаú)
±³À°½Ã°£ 03-12 Room 3 14:00~14:20 ¼Ò¾Æû¼Ò³â °íµµºñ¸¸ÀÇ ¿µ¾ç¿ä¹ý ÀÓÇöÁ¤(°æÈñ´ëÇб³ ÀÇÇпµ¾çÇаú)
±³À°½Ã°£ 03-12 Room 3 14:20~14:40 ¼Ò¾Æû¼Ò³â °íµµºñ¸¸ÀÇ ¾à¹°Ä¡·á Á¤Çý¿î(°æÈñÀÇ´ë ¼Ò¾Æû¼Ò³â°ú)
±³À°½Ã°£ 03-12 Room 3 14:40~15:00 ¼Ò¾Æû¼Ò³â °íµµºñ¸¸ÀÇ ¼ö¼úÄ¡·á ¹Ú¿µ¼®(¼¿ïÀÇ´ë ºñ¸¸´ë»ç¿Ü°ú)
Åä·Ð 03-12 Room 3 15:00~15:20 ÆгÎÅäÀÇ ÀÌ¿µÁØ, ±èÀçÇö(°í·ÁÀÇ´ë ¾È»êº´¿ø ¼Ò¾Æû¼Ò³â°ú, ºÐ´ç¼¿ï´ëº´¿ø ¼Ò¾Æû¼Ò³â°ú)
±³À°½Ã°£ 03-12 Room 1 15:30~16:00 ´ç´¢º´ ¿¹¹æ ±ÇÇõ»ó(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03-12 Room 2 15:30~16:00 ºòµ¥ÀÌÅÍ¿¬±¸ ÇÑ°æµµ(¼þ½Ç´ë)
±³À°½Ã°£ 03-12 Room 3 15:30~16:00 ºñ¸¸½Ä»ç¿ä¹ýÀÇ Ã¼°èÀû ¹®Çå°íÂû°ú ´ÙÇÐÁ¦ ±Ç°í¾È ±è°æ°ï(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 03-12 Room 1 16:00~16:20 Obesity and sleep ±èÁø¿í(À»ÁöÀÇ´ë °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 03-12 Room 1 16:20~16:40 Obesity and cancer °íÇýÁø(°æºÏÀÇ´ë °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 03-12 Room 1 16:40~17:00 Obesity and cognitive function Á¤ÁöÇâ(ÀÌÈÀÇ´ë ½Å°æ°ú)
Åä·Ð 03-12 Room 1 17:00~17:20 ÆгÎÅäÀÇ ¹Ú°æÈñ, ȲÀ¯Ã¶(ÇѸ²ÀÇ´ë °¡Á¤ÀÇÇаú, °æÈñÀÇ´ë °µ¿°æÈñ´ëº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03-12 Room 2 16:00~16:20 ºñ¸¸°ú °Ç°¼ö¸í, ±â´ë¿©¸í ¼ÕÀå¿ø(°¡Å縯ÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03-12 Room 2 16:20~16:40 ºñ¸¸´ë»çÁúȯ¿¡¼ÀÇ µðÁöÅÐÄ¡·áÁ¦ÀÇ ÀÓ»óÀû È°¿ë ÇѺ´´ö(°í·ÁÀÇ´ë °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 03-12 Room 2 16:40~17:00 ºñ¸¸°ú ÀÎÁö±â´É ÀúÇÏ ¹× Ä¡¸Å ³²°¡Àº(°í·ÁÀÇ´ë °¡Á¤ÀÇÇаú)
Åä·Ð 03-12 Room 2 17:00~17:20 ÆгÎÅäÀÇ ÀÌ»ó¿, ÀÌÀçÇõ(°æÈñÀÇ´ë °æÈñ´ëº´¿ø ³»ºÐºñ´ë»ç³»°ú, ÇѾç´ë ¸íÁöº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03-12 Room 3 16:00~16:20 Lactate acts as an anti-obesity metabolite through acceleration of lipid metabolism °íÁøÈ£(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 03-12 Room 3 16:20~16:40 The identification of exercise-induced genes encoding secretory peptides in the young and the elderly ·ùµ¿·Ä(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03-12 Room 3 16:40~17:00 Role of fitness in the metabolically healthy obesity Á¦¼¼¿µ(¼¿ï½Ã¸³´ëÇб³)
Åä·Ð 03-12 Room 3 17:00~17:20 ÆгÎÅäÀÇ ±èÁ¾Èñ, À̼¼¿ø(ÇѾç´ë üÀ°Çаú, ÀÎõ´ë)